Elutia Inc (ELUT)

Cantor Fitzgerald Weighs in on Elutia Inc.'s FY2024 Earnings (NASDAQ:ELUT) - MarketBeat

MarketBeat

Head-To-Head Contrast: Elutia (NASDAQ:ELUT) & Fennec Pharmaceuticals (NASDAQ:FENC) - Defense World

Defense World

Elutia Inc. to Post FY2024 Earnings of ($1.37) Per Share, Cantor Fitzgerald Forecasts (NASDAQ:ELUT) - Defense World

Defense World

Lake Street Capital Raises Elutia (NASDAQ:ELUT) Price Target to $10.00 - MarketBeat

MarketBeat

FDA clears new drug-eluting envelope for implantable cardiac devices—CEO sees it as 'tip of the iceberg' - Cardiovascular Business

Cardiovascular Business

FDA clears new drug-eluting envelope for implantable cardiac devices—CEO sees it as 'tip of the iceberg' - Cardiovascular Business

Cardiovascular Business

Was Elutia Inc (ELUT)'s session last reading good? – US Post News - US Post News

US Post News

Cantor Fitzgerald Boosts Elutia (NASDAQ:ELUT) Price Target to $11.00 - MarketBeat

MarketBeat

Elutia announces FDA clearance of EluPro - TipRanks.com - TipRanks

TipRanks

Elutia announces FDA clearance of EluPro - TipRanks.com - TipRanks

TipRanks

Elutia Inc (ELUT) Stock: A Year of Stock Market Ups and Downs - The InvestChronicle

The InvestChronicle

Elupro - BioWorld Online

BioWorld Online

Elutia to sell 3.18M shares at $3.40 in registered direct offering - TipRanks.com - TipRanks

TipRanks

Elutia Announces FDA Clearance of EluPro: The First Antibiotic-Eluting BioEnvelope Designed to Protect Patients with ... - Diagnostic and Interventional Cardiology

Diagnostic and Interventional Cardiology

Elutia Announces $13.26 Million Registered Direct Offering - citybiz

citybiz

FDA clears Elutia's bioenvelope to protect implanted devices - BioWorld Online

BioWorld Online

Aziyo Biologics Gains FDA Clearance for EluPro® Bioenvelope - TipRanks.com - TipRanks

TipRanks

SEC Form 424B5 filed by Elutia Inc. - Quantisnow

Quantisnow

Elutia Announces $13.26 Million Registered Direct Offering - ForexTV.com

ForexTV.com

Elutia Announces $13.26 Million Registered Direct Offering - ForexTV.com

ForexTV.com

Elutia Announces $13.26 Million Registered Direct Offering | ELUT Stock News - StockTitan

StockTitan

Elutia Announces FDA Clearance of EluPro®: The First Antibiotic-Eluting BioEnvelope Designed to Protect Patients ... - StockTitan

StockTitan

FDA Announces Teleflex/Arrow International Recall Arrow FiberOptix and UltraFlex Intra-Aortic Balloon (IAB) Catheter ... - Diagnostic and Interventional Cardiology

Diagnostic and Interventional Cardiology

Philips launches Duo Venous Stent System for Treatment of Symptomatic Venous Outflow Obstruction - Diagnostic and Interventional Cardiology

Diagnostic and Interventional Cardiology

Elutia Inc. (NASDAQ:ELUT) Short Interest Down 62.4% in May - MarketBeat

MarketBeat

Elutia (NASDAQ:ELUT) Stock Price Up 1.7% - MarketBeat

MarketBeat

Elutia (NASDAQ:ELUT) Trading Up 1.7% - Defense World

Defense World

Elutia (NASDAQ:ELUT) Stock Price Up 1.7% - MarketBeat

MarketBeat

Cardiac Care AI Company, Anumana, Announces Receipt of ISO 13485 Certification - Diagnostic and Interventional Cardiology

Diagnostic and Interventional Cardiology

Elutia to Showcase BioEnvelope Product Line at Heart Rhythm 2024 - Investing.com India

Investing.com India

Elutia First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags - Simply Wall St

Simply Wall St

Elutia, Inc. (ELUT) Q1 2024 Earnings Call Transcript - Seeking Alpha

Seeking Alpha

Elutia (NASDAQ:ELUT) PT Lowered to $5.00 at Cantor Fitzgerald - MarketBeat

MarketBeat

Elutia (NASDAQ:ELUT) PT Lowered to $5.00 at Cantor Fitzgerald - MarketBeat

MarketBeat

SimpliDerm Sales Increase 55%, CanGarooRM on Track for Second Quarter 2024 FDA Clearance - wallstreet:online

wallstreet:online

Elutia (ELUT) to Release Earnings on Thursday - Defense World

Defense World

DAIC's Top 10 for April | DAIC - Diagnostic and Interventional Cardiology

Diagnostic and Interventional Cardiology

Elutia to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1

GlobeNewswire Inc.

Cardiology Team Performs Novel Heart Artery Repair with Newly Approved Device - Diagnostic and Interventional Cardiology

Diagnostic and Interventional Cardiology

FDA Announces Medos International Sàrl Recall of Cerenovus CEREBASE DA Guide Sheath due to Cracking of the ... - Diagnostic and Interventional Cardiology

Diagnostic and Interventional Cardiology

Abbott Announces FDA Approval of First-of-its-kind Device to Repair Leaky Tricuspid Heart Valve, TriClip - Diagnostic and Interventional Cardiology

Diagnostic and Interventional Cardiology

Elixir Medical Receives FDA Breakthrough Device Designation for DynamX BTK System for Below-The-Knee Arterial ... - Diagnostic and Interventional Cardiology

Diagnostic and Interventional Cardiology

Siemens Healthineers Announces FDA Clearance of CIARTIC Move Self-Driving Mobile C-arm - Diagnostic and Interventional Cardiology

Diagnostic and Interventional Cardiology

FDA Breakthrough Device Designation for Biotronik Freesolve Below-the-Knee Resorbable Magnesium Scaffold (RMS) - Diagnostic and Interventional Cardiology

Diagnostic and Interventional Cardiology

Getinge Announces US FDA 510(k) Clearance for Vasoview Hemopro 3 Endoscopic Vessel Harvesting (EVH) solution - Diagnostic and Interventional Cardiology

Diagnostic and Interventional Cardiology

Elutia Full Year 2023 Earnings: Misses Expectations - Yahoo Finance

Yahoo Finance

ELUT Stock Earnings: Elutia Misses EPS, Misses Revenue for Q4 2023 - InvestorPlace

InvestorPlace

Lantheus Announces the FDA Approval of DEFINITY as Ultrasound Enhancing Agent for Use in Certain Pediatric ... - Diagnostic and Interventional Cardiology

Diagnostic and Interventional Cardiology

Boston Scientific Receives FDA Approval for the AGENT Drug-Coated Balloon - Diagnostic and Interventional Cardiology

Diagnostic and Interventional Cardiology

Elutia to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, March 7, 2024

GlobeNewswire Inc.